Clinical Experience of Continuous Glucose Monitoring in Pregnancy

Grenye O’Malley; Barak Rosenn; Emily V. Nosova; Yogish C. Kudva; Sophia Scarpelli Shchur; Camilla Levister; Ravinder Kaur; Jordan E. Pinsker; Kristin Castorino; Mei Mei Church; Eyal Dassau; Carol J. Levy

doi:10.1177/19322968211024668

Clinical Experience of Continuous Glucose Monitoring in Pregnancy

Grenye O’Malley, Barak Rosenn, Emily V. Nosova, Yogish C. Kudva, Sophia Scarpelli Shchur, Camilla Levister, Ravinder Kaur, Jordan E. Pinsker, Kristin Castorino, Mei Mei Church, Eyal Dassau, Carol J. Levy

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1402-1403
Number of pages	2
Journal	Journal of diabetes science and technology
Volume	15
Issue number	6
DOIs	https://doi.org/10.1177/19322968211024668
State	Published - 2021

Access to Document

10.1177/19322968211024668

Cite this

@article{ea5d290d30ea45c68c577664bc483592,

title = "Clinical Experience of Continuous Glucose Monitoring in Pregnancy",

author = "Grenye O{\textquoteright}Malley and Barak Rosenn and Nosova, {Emily V.} and Kudva, {Yogish C.} and {Scarpelli Shchur}, Sophia and Camilla Levister and Ravinder Kaur and Pinsker, {Jordan E.} and Kristin Castorino and Church, {Mei Mei} and Eyal Dassau and Levy, {Carol J.}",

note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GO receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. BR has no disclosures to report. EVN has no disclosures to report. YCK receives consulting fees from Novo Nordisk and product support from Dexcom, Roche Diabetes, and Tandem Diabetes. SSS has no disclosures to report. CL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. RK has no disclosures to report. JEP is currently an employee of Tandem Diabetes Care, Inc. The work presented in the manuscript was performed as part of his academic appointment at Sansum Diabetes Research Institute and is independent of his employment with Tandem Diabetes Care. KC receives research support from Dexcom, Medtronic, Abbott, Insulet, and Novo Nordisk paid to her institution. MMC has no disclosures to report. ED reports receiving grants from JDRF, NIH, and Helmsley Charitable Trust, personal fees from Roche, Dexcom and Eli Lilly, patents on artificial pancreas technology, and product support from Dexcom, Insulet, Tandem, and Roche. ED is currently an employee and shareholder of Eli Lilly and Company. The work presented in this manuscript was performed as part of his academic appointment and is independent of his employment with Eli Lilly and Company. CJL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution and has served as a consultant and CME speaker for Dexcom and as a consultant for Eli Lilly. ",

year = "2021",

doi = "10.1177/19322968211024668",

language = "English",

volume = "15",

pages = "1402--1403",

journal = "Journal of diabetes science and technology",

issn = "1932-2968",

publisher = "SAGE Publications Inc.",

number = "6",

}

TY - JOUR

T1 - Clinical Experience of Continuous Glucose Monitoring in Pregnancy

AU - O’Malley, Grenye

AU - Rosenn, Barak

AU - Nosova, Emily V.

AU - Kudva, Yogish C.

AU - Scarpelli Shchur, Sophia

AU - Levister, Camilla

AU - Kaur, Ravinder

AU - Pinsker, Jordan E.

AU - Castorino, Kristin

AU - Church, Mei Mei

AU - Dassau, Eyal

AU - Levy, Carol J.

N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GO receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. BR has no disclosures to report. EVN has no disclosures to report. YCK receives consulting fees from Novo Nordisk and product support from Dexcom, Roche Diabetes, and Tandem Diabetes. SSS has no disclosures to report. CL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. RK has no disclosures to report. JEP is currently an employee of Tandem Diabetes Care, Inc. The work presented in the manuscript was performed as part of his academic appointment at Sansum Diabetes Research Institute and is independent of his employment with Tandem Diabetes Care. KC receives research support from Dexcom, Medtronic, Abbott, Insulet, and Novo Nordisk paid to her institution. MMC has no disclosures to report. ED reports receiving grants from JDRF, NIH, and Helmsley Charitable Trust, personal fees from Roche, Dexcom and Eli Lilly, patents on artificial pancreas technology, and product support from Dexcom, Insulet, Tandem, and Roche. ED is currently an employee and shareholder of Eli Lilly and Company. The work presented in this manuscript was performed as part of his academic appointment and is independent of his employment with Eli Lilly and Company. CJL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution and has served as a consultant and CME speaker for Dexcom and as a consultant for Eli Lilly.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85109097062&partnerID=8YFLogxK

U2 - 10.1177/19322968211024668

DO - 10.1177/19322968211024668

M3 - Letter

C2 - 34218719

AN - SCOPUS:85109097062

SN - 1932-2968

VL - 15

SP - 1402

EP - 1403

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

IS - 6

ER -